Warwick SAS Medical Limited - Accounts to registrar (filleted) - small 22.3
Warwick SAS Medical Limited - Accounts to registrar (filleted) - small 22.3
REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 30 JUNE 2022 |
FOR |
WARWICK SAS MEDICAL LIMITED |
PREVIOUSLY KNOWN AS |
WARWICK PROJECTS LIMITED |
WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990) |
PREVIOUSLY KNOWN AS WARWICK PROJECTS LIMITED |
CONTENTS OF THE FINANCIAL STATEMENTS |
for the year ended 30 June 2022 |
Page |
Company Information | 1 |
Abridged Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
WARWICK SAS MEDICAL LIMITED |
PREVIOUSLY KNOWN AS WARWICK PROJECTS LIMITED |
COMPANY INFORMATION |
for the year ended 30 June 2022 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990) |
PREVIOUSLY KNOWN AS WARWICK PROJECTS LIMITED |
ABRIDGED BALANCE SHEET |
30 June 2022 |
2022 | 2021 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Investments | 4 |
CURRENT ASSETS |
Debtors |
CREDITORS |
Amounts falling due within one year |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 5 |
Share premium |
Retained earnings |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990) |
PREVIOUSLY KNOWN AS WARWICK PROJECTS LIMITED |
NOTES TO THE FINANCIAL STATEMENTS |
for the year ended 30 June 2022 |
1. | STATUTORY INFORMATION |
Warwick SAS Medical Limited is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. |
The financial statements are presented in sterling which is the functional currency of the company and is rounded to the nearest £1. |
Preparation of consolidated financial statements |
The financial statements contain information about Warwick SAS Medical Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements. |
Investments in subsidiaries |
Investments in subsidiary undertakings are recognised at cost. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
4. | FIXED ASSET INVESTMENTS |
Information on investments other than loans is as follows: |
Totals |
£ |
COST |
At 1 July 2021 |
and 30 June 2022 | 3,200,008 |
NET BOOK VALUE |
At 30 June 2022 | 3,200,008 |
At 30 June 2021 | 3,200,008 |
5. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2022 | 2021 |
value: | £ | £ |
Ordinary A | 1p | 113 | 113 |
Ordinary B | £1 | 90 | 90 |
203 | 203 |
WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990) |
PREVIOUSLY KNOWN AS WARWICK PROJECTS LIMITED |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 30 June 2022 |
6. | RELATED PARTY DISCLOSURES |
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |